|
NOW ENROLLING! A clinical research trial for patients with ULCERATIVE COLITIS.
What is this trial?
This is a study for Ulcerative Colitis patients designed to evaluate a human monoclonal antibody (adalimumab).
Patients must meet the following criteria:
- Diagnosed with active ulcerative colitis, confirmed by endoscopy with biopsy
- 18 years of age or older
- Moderately to severely active ulcerative colitis
- Receiving or have tried corticosteroids and/or immunosuppressive therapy
- May be eligible if previously treated with inflixiimab or other anti-TNF agents
- Not participating in any other investigational agent trials
For more information call Jennifer Nikolich at (203) 281-5161 or Nancy Ferguson at (203) 281-4463 ext. 5184
|
